Intravenous administration of recombinant mouse progranulin (300 μg/kg) immediately before ligation of LCA significantly reduced myocardial infarct size by 21% compared with vehicle-treated group 24 h after permanent occlusion of the LCA (Fig. 3A, B). The gene discussed is GRN; the disease is myocardial infarction.